MTOR and inflammatory skin disease: Because of the width of this topic, in this section we mainly discuss the implications of mTOR signaling pathway in keratinocyte carcinomas (also known as non-melanoma skin cancers, NMSC), in particular basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), and inflammatory skin diseases, such as psoriasis and AD.